What is Henry Schein, Inc. share price today?

Henry Schein, Inc. (HSIC) share price today is {{live_price}}.

Can Indians buy Henry Schein, Inc. shares?

Yes, Indians can invest in the Henry Schein, Inc. (HSIC) from India. With INDmoney, you can buy Henry Schein, Inc. at 0 brokerage. The step-by-step process is as follows: Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes) Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates. Once funds are transferred successfully, you can buy Henry Schein, Inc. at zero transaction cost.

How can I buy Henry Schein, Inc. shares from India?

It is very easy to buy Henry Schein, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Henry Schein, Inc. be purchased?

Yes, you can buy fractional shares of Henry Schein, Inc. with INDmoney app.

What are the documents required to start investing in Henry Schein, Inc. stocks?

To start investing in Henry Schein, Inc., You will need the following documents: Proof of Identification (PAN, Aadhaar etc) Proof of address (Aadhaar, Voter ID etc) These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Henry Schein, Inc.

Today’s highest price of Henry Schein, Inc. (HSIC) is {{1_rba_end}}. Today’s lowest price of Henry Schein, Inc. (HSIC) is {{1_rba_st}}.

What is today's market capitalisation of Henry Schein, Inc.

Today's market capitalisation of Henry Schein, Inc. HSIC is 8.9B

What is the 52 Week High and Low Range of Henry Schein, Inc.

52 Week High {{rba_end}} 52 Week Low {{rba_st}}

How much percentage Henry Schein, Inc. is down from its 52 Week High?

Henry Schein, Inc. (HSIC) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

How much percentage Henry Schein, Inc. is up from its 52 Week low?

Henry Schein, Inc. (HSIC) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

What are the historical returns of Henry Schein, Inc.?

1 Month Returns {{1mr}}% 3 Months Returns {{3mr}}% 1 Year Returns {{1yr}}% 5 Years Returns {{5yr}}%

Who is the Chief Executive Officer (CEO) of Henry Schein, Inc.

Mr. Stanley M. Bergman is the current Chief Executive Officer (CEO) of Henry Schein, Inc..

Home>
US Stocks>
Henry Schein, Inc.

Henry Schein, Inc. (HSIC)

$70.56

+0.02

(+0.03%)▲

Market is closed - opens 7 PM, 07 Oct 2024

Performance

$70.17
$71.30
$70.56
0.55%
Downside
Day's Volatility :1.58%
Upside
1.04%
$60.01
$82.63
$70.56
14.95%
Downside
52 Weeks Volatility :27.38%
Upside
14.61%

Returns

Period	Henry Schein, Inc.	Sector (Health Care)	S&P500
3 Months	8.97%	5.0%	3.3%
6 Months	-2.64%	5.9%	10.5%
1 Year	-4.66%	16.6%	33.5%
3 Years	-11.48%	18.9%	30.7%

Highlights

Market Capitalization	8.9B
Book Value	$27.64
Earnings Per Share (EPS)	2.71
PE Ratio	26.04
PEG Ratio	1.58
Wall Street Target Price	72.6

Profit Margin	2.82%
Operating Margin TTM	5.68%

Return On Assets TTM	3.89%
Return On Equity TTM	7.25%

Revenue TTM	12.5B
Revenue Per Share TTM	96.67
Quarterly Revenue Growth YOY	1.2%
Gross Profit TTM	3.8B
EBITDA	887.0M
Diluted Eps TTM	2.71
Quarterly Earnings Growth YOY	-0.24

EPS Estimate Current Year	4.75
EPS Estimate Next Year	5.28
EPS Estimate Current Quarter	1.22
EPS Estimate Next Quarter	1.34

Analyst Recommendation

Hold

42%Buy

47%Hold

9%Sell

Based on 21 Wall street analysts offering stock ratings for Henry Schein, Inc.(by analysts ranked 0 to 5 stars)

Based on 21 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast

What analysts predicted

Upside of 2.89%

Current $70.56

Target $72.60

Company Financials

	FY18	Y/Y Change
Revenue	13.2B	↑ 5.94%
Net Income	535.9M	↑ 31.89%
Net Profit Margin	4.06%	↑ 0.8%

	FY19	Y/Y Change
Revenue	10.0B	↓ 24.36%
Net Income	520.8M	↓ 2.82%
Net Profit Margin	5.22%	↑ 1.16%

	FY20	Y/Y Change
Revenue	10.1B	↑ 1.34%
Net Income	403.8M	↓ 22.47%
Net Profit Margin	3.99%	↓ 1.23%

	FY21	Y/Y Change
Revenue	12.4B	↑ 22.55%
Net Income	631.0M	↑ 56.27%
Net Profit Margin	5.09%	↑ 1.1%

	FY22	Y/Y Change
Revenue	12.6B	↑ 1.98%
Net Income	538.0M	↓ 14.74%
Net Profit Margin	4.25%	↓ 0.84%

	FY23	Y/Y Change
Revenue	12.3B	↓ 2.44%
Net Income	416.0M	↓ 22.68%
Net Profit Margin	3.37%	↓ 0.88%

	Q1 FY23	Q/Q Change
Revenue	3.1B	↓ 9.23%
Net Income	121.0M	↑ 157.45%
Net Profit Margin	3.95%	↑ 2.56%

	Q2 FY23	Q/Q Change
Revenue	3.1B	↑ 1.31%
Net Income	140.0M	↑ 15.7%
Net Profit Margin	4.52%	↑ 0.57%

	Q3 FY23	Q/Q Change
Revenue	3.2B	↑ 2.0%
Net Income	137.0M	↓ 2.14%
Net Profit Margin	4.33%	↓ 0.19%

	Q4 FY23	Q/Q Change
Revenue	3.0B	↓ 4.59%
Net Income	18.0M	↓ 86.86%
Net Profit Margin	0.6%	↓ 3.73%

	Q1 FY24	Q/Q Change
Revenue	3.2B	↑ 5.14%
Net Income	93.0M	↑ 416.67%
Net Profit Margin	2.93%	↑ 2.33%

	Q2 FY24	Q/Q Change
Revenue	3.1B	↓ 1.13%
Net Income	104.0M	↑ 11.83%
Net Profit Margin	3.32%	↑ 0.39%

	FY18	Y/Y Change
Total Assets	8.5B	↑ 8.82%
Total Liabilities	5.0B	↑ 19.35%

	FY19	Y/Y Change
Total Assets	7.2B	↓ 15.87%
Total Liabilities	3.5B	↓ 28.99%

	FY20	Y/Y Change
Total Assets	7.8B	↑ 8.69%
Total Liabilities	3.8B	↑ 7.59%

	FY21	Y/Y Change
Total Assets	8.5B	↑ 9.12%
Total Liabilities	4.4B	↑ 16.62%

	FY22	Y/Y Change
Total Assets	8.6B	↑ 1.48%
Total Liabilities	3.9B	↓ 10.91%

	FY23	Y/Y Change
Total Assets	10.6B	↑ 22.84%
Total Liabilities	5.4B	↑ 37.7%

	Q1 FY23	Q/Q Change
Total Assets	8.6B	↓ 0.41%
Total Liabilities	3.9B	↓ 1.55%

	Q2 FY23	Q/Q Change
Total Assets	9.1B	↑ 6.7%
Total Liabilities	4.1B	↑ 6.84%

	Q3 FY23	Q/Q Change
Total Assets	9.8B	↑ 7.26%
Total Liabilities	4.7B	↑ 13.74%

	Q4 FY23	Q/Q Change
Total Assets	10.6B	↑ 7.78%
Total Liabilities	5.4B	↑ 15.1%

	Q1 FY24	Q/Q Change
Total Assets	10.1B	↓ 4.05%
Total Liabilities	5.1B	↓ 5.72%

	Q2 FY24	Q/Q Change
Total Assets	10.3B	↑ 1.04%
Total Liabilities	5.2B	↑ 2.68%

	FY18	Y/Y Change
Operating Cash Flow	684.7M	↑ 25.52%
Investing Cash Flow	-193.0M	↓ 43.63%
Financing Cash Flow	-603.8M	↑ 436.45%

	FY19	Y/Y Change
Operating Cash Flow	654.1M	↓ 4.47%
Investing Cash Flow	-424.4M	↑ 119.93%
Financing Cash Flow	-216.0M	↓ 64.23%

	FY20	Y/Y Change
Operating Cash Flow	598.9M	↓ 8.44%
Investing Cash Flow	-115.0M	↓ 72.9%
Financing Cash Flow	-187.2M	↓ 13.33%

	FY21	Y/Y Change
Operating Cash Flow	709.6M	↑ 18.48%
Investing Cash Flow	-677.2M	↑ 488.79%
Financing Cash Flow	-333.0M	↑ 77.88%

	FY22	Y/Y Change
Operating Cash Flow	602.0M	↓ 15.16%
Investing Cash Flow	-276.0M	↓ 59.24%
Financing Cash Flow	-315.0M	↓ 5.39%

	Q1 FY23	Q/Q Change
Operating Cash Flow	27.0M	↓ 89.37%
Investing Cash Flow	-39.0M	↓ 40.0%
Financing Cash Flow	21.0M	↓ 110.82%

	Q2 FY23	Q/Q Change
Operating Cash Flow	274.0M	↑ 914.81%
Investing Cash Flow	-301.0M	↑ 671.79%
Financing Cash Flow	38.0M	↑ 80.95%

Technicals Summary

Sell

Neutral

Buy

Henry Schein, Inc. is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Henry Schein, Inc.	2.42%	-2.64%	-4.66%	-11.48%	12.21%
Cardinal Health, Inc.	-0.73%	2.29%	23.42%	128.53%	145.57%
Cencora Inc	-7.01%	-8.07%	18.13%	56.64%	83.82%
Mckesson Corporation	-5.33%	-9.39%	6.75%	141.62%	270.32%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Henry Schein, Inc.	26.04	26.04	1.58	4.75	0.07	0.04	NA	27.64
Cardinal Health, Inc.	32.46	32.46	0.96	7.36	0.0	0.03	0.02	-13.17
Cencora Inc	24.04	24.04	1.25	13.63	1.88	0.03	0.01	4.7
Mckesson Corporation	21.69	21.69	1.41	27.59	0.0	0.04	0.01	-13.53

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Henry Schein, Inc.	Hold	$8.9B	12.21%	26.04	2.82%
Cardinal Health, Inc.	Hold	$27.1B	145.57%	32.46	0.38%
Cencora Inc	Buy	$43.4B	83.82%	24.04	0.65%
Mckesson Corporation	Buy	$62.9B	270.32%	21.69	0.94%

Insights on Henry Schein, Inc.

Decreasing Revenue
Revenue is down for the last 2 quarters, 3.17B → 3.13B (in $), with an average decrease of 1.1% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, 18.0M → 104.0M (in $), with an average increase of 45.6% per quarter
Vs CAH
In the last 1 year, Cardinal Health, Inc. has given 24.5% return, outperforming this stock by 29.6%
Vs MCK
In the last 3 years, Mckesson Corporation has given 128.5% return, outperforming this stock by 140.0%